Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Ren
M. Ren
Novartis
Secukinumab
Immunology
Interleukin 17
Psoriatic arthritis
Monoclonal antibody
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years
2019
Journal of The European Academy of Dermatology and Venereology
K. Reich
Andrew Blauvelt
April W. Armstrong
R.G. Langley
A. de Vera
Frank Kolbinger
Sebastian Spindeldreher
M. Ren
Gerard Bruin
Show All
Source
Cite
Save
Citations (11)
SAT0271 Secukinumab, a fully human anti-interleukin-17a monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52-week treatment period
2018
Annals of the Rheumatic Diseases
Atul Deodhar
Dafna D. Gladman
Iain B. McInnes
M. Ren
Sebastian Spindeldreher
Luminita Pricop
Brian Porter
Jorge Safi
Abhijit Shete
Gerard Bruin
Show All
Source
Cite
Save
Citations (5)
Physics of Fluids
1997
G.J. de Bruin
A.S. (Anna) von der Heydt
Sascha Hilgenfeldt
Irene Mazzitelli
Claus-Dieter Ohl
R.E.G. Poorte
Andrea Prosperetti
M. Ren
Judith Rensen
R. Tögel
H. G. M. Velthuizen
A.M (Michel) Versluis
Detlef Lohse
L. van Wijngaarden
Show All
Source
Cite
Save
Citations (0)
1